Functional genomics approach to understanding sepsis heterogeneity by Le, Kieu
  
 University of Groningen




IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Le, K. (2019). Functional genomics approach to understanding sepsis heterogeneity. [Groningen]:
University of Groningen. https://doi.org/10.33612/diss.98318779
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the






In this thesis we aimed to understand the heterogeneity in sepsis by delineating the contribution 
of pathogens and host genetics factors. Using a functional genomics approach, we integrated 
multi-omics data with functional experiments in the laboratory to understand the molecular 
mechanisms behind sepsis heterogeneity. In this final chapter, I will discuss the impact of 
our findings for future research in sepsis, and the possibilities for better delineating sepsis 
















































































































































































































Host immune responses in sepsis are 
not solely determined by leukocytes, 
but also by the leukocyte-endothelial 
cell interaction.
It is known that the innate immune 
defense includes various cell types and 
processes. The body barriers, composed of 
the epithelium and endothelium, serve as 
the frontier in preventing pathogen invasion. 
Different cell types can participate in different 
manners: engulfing the pathogens, responding 
to Pathogen- Associated Molecular Pattern 
(PAMP) and Damage- Associated Molecular 
Pattern (DAMP) factors. We have also 
now shown that, in addition to leukocytes, 
endothelial cells actively regulate inflammation. 
Endothelial cells can secrete cytokines 
and increase the total amount of circulating 
inflammatory cytokines, as I showed at both 
the transcriptome level (chapter 4) and the 
protein level (Appendix). Upon exposure to 
endotoxin, endothelial cells can actively secrete 
cytokines such as IL-6 and IL-8; chemokines 
such as CXCL1, CXCL6 and CX3CL1; and 
extracellular matrix proteinases such as 
MMP10 (Figure S1). Moreover, although whole 
lysates from various pathogens induce strong 
variations in leukocyte response, they do not 
activate endothelial cells directly. Instead, 
endothelial responses to whole pathogen 
lysates are dependent on inflammatory 
mediators secreted by activated leukocytes 
(Figure S2) likely due to the limited presence of 
pathogen-recognizing motifs (Molema, 2010). 
The cytokines secreted by endothelial cells 
upon stimulation are also significantly different 
in the serum of candidemia patients than the 
cytokines found in healthy controls (chapter 
3), indicating the important role endothelial 
cells play in determining the total amount of 
cytokines and chemokines circulated in sepsis.
Inflammation is central to the fight against 
infectious pathogens, but it should not 
be the sole focus in sepsis research. 
Systemic inflammatory response to 
infection has been used as the clinical criteria 
to recognize sepsis patients (Bone et al., 1992, 
Levy et al., 2003). However, although this 
emphasizes the critical roles of infection and 
regulation of inflammation in sepsis, it does 
not capture other important host responses. 
In 2016, the definition of sepsis was updated 
to focus on organ failure in the host as the 
consequence of sepsis, while emphasizing 
a dysregulated host response to infection as 
an etiology (sepsis-3). In accordance with the 
sepsis-3 definition, we show in chapters 2-4 
that other cellular processes in the host are 
also important to sepsis onset and mortality.
Vascular and intestinal barrier functions 
are important in sepsis. 
By performing pathway enrichment 
analysis on genes from genetic loci associated 
with sepsis, we showed an enrichment of 
genes for the adherens junction pathway, 
indicating a role for barrier function in sepsis 
(chapter 2). Binding to adherens junction 
molecules is known to be a factor in microbial 
competence. To promote colonization, 
opportunistic pathogens can attach their 
cellular wall to the different proteins that 
constitute the adherens junctions. For 
example, Streptococcus pneumonia targets 
E-cadherin on the epithelial surface (Anderton 
et al., 2007) while Listeria monocytogenes 
attach to E-cadherin to promote colonization 
intracellularly (Lecuit et al., 2000). Pathogens 
can also target different proteins depending 
on the host cell type. Candida albicans, for 
example, adheres to N-cadherin on endothelial 
cells and to E-cadherin on oral epithelial cells 
to promote extracellular colonization (Phan et 
al., 2007). Bacteria can also secrete proteases 
that cleave the adherens junctions, such as 
Sap5p from Candida albicans (Villar et al., 
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2007) and α-hemolysin from Staphylococcus 
aureus (Inoshima et al., 2011), thereby 
facilitating deep invasion of bacteria into 
tissues. Therefore, a compromised barrier on 
the host tissues will allow bacterial invasion 
of the host. Together with the tight junction, 
the adherens junction constitutes the barrier 
that prevents the pathogens from spreading 
more widely. The endothelial barrier protects 
the tissues and organs from infiltration of fluid, 
whereas the intestinal barrier protects the 
body from the invasion of the gut microbiota.
The endothelial barrier maintains 
vascular integrity and vascular leakage is a 
common manifestation in sepsis (Van Der Poll 
et al., 2017). However, the level of leakage is 
different in each organ, probably due to the 
specific characteristics of the endothelium in 
different vascular beds (Aslan et al., 2017). 
In fact, Hakanpaa et al were able to inhibit 
vascular leakage in an LPS-challenged sepsis 
mouse model by neutralizing β1-integrin, 
thereby protecting cardiac failure (Hakanpaa 
et al., 2018). However, it remains to be studied 
how endothelial responses to infection in 
different vascular beds and organs contribute 
to organ dysfunction in sepsis.
On the other hand, the intestinal barrier 
is made up of epithelial cells. Epithelial cells 
can be damaged due to apoptosis, induced 
by pro-inflammatory cytokines such as TNF-α 
and IFN-ϒ (Cao et al., 2013). Recently, Cao 
et al confirmed the disruption of the intestinal 
barrier in an LPS-challenged mouse sepsis 
model. The ability to balance proliferation and 
apoptosis of the epithelium was disrupted in 
sepsis, which resulted in decreased mucosa 
thickness and increased permeability (Cao et 
al., 2018). The intestinal barrier is, therefore, 
pivotal for protecting the body from the 
microbiota in the gut. The loss of a barrier in 
the gut during inflammation could serve as 
the gateway for the spreading of pathogens 
into the blood stream. Although Tamburini et al 
observed that the dominant bacteria in the gut 
are also present in the blood stream of sepsis 
patients (Tamburini et al., 2018), more research 
is needed to determine if the gut bacteria are 
the source of infection that causes sepsis, or if 
inflammation in sepsis allows the penetration 
of the gut bacteria to the bloodstream.
The role of the IFN pathway in coagulation.
Inflammation can initiate coagulation 
via two factors: cells and cytokine mediators. 
In sepsis, coagulation is abundant and 
disseminated in the blood vessels. 
Coagulation, or blood clotting, is a stable net 
formed by fibrin, an end product initiated by 
the adhesion of platelets to the vascular wall, 
the endothelium. Coagulation can be activated 
by an intrinsic pathway (initiated by damage 
to the blood vessel surface) or by an extrinsic 
pathway (responding to infection via the 
presence of tissue factor). During inflammation, 
the endothelium expresses Willebrand Factor 
(vWF) to support the anchoring of platelets 
to the blood vessel (Reininger, 2008). The 
endothelium also produces tissue factor 
to initiate the extrinsic pathway, as well as 
plasminogen activator inhibitor Type 1 (PAI-1) 
to inhibit the degradation of the fibrin clot (Levi 
& van der Poll, 2017). On the other hand, pro-
inflammatory cytokines such as IL-6 and IL-1 
can also facilitate coagulation (van der Poll 
et al., 1994; Boermeester et al., 1995). But 
are they the only cytokines that can induce 
coagulation? In chapter 4, we observed that 
IFN pathways were induced in endothelial 
cells by inflammatory mediators secreted by 
leukocytes, and this occurred independently of 
IL1 and TNF-α. We noticed that the activation 
of IFN pathways did not induce a major 
inflammatory response in endothelial cells. 
To date there is little evidence on the role of 
the IFN pathway in endothelial cells, although 
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recent work suggested that IFN pathways 
can impair fibrinolysis, leading to malleable 
coagulation (Jia et al., 2018).
As a proof of principle, we performed an 
experiment in which endothelial cells were 
seeded in a microfluidic device that mimics 
flow in the blood vessels. Endothelial cells 
were pre-activated by exposure to TNF-α or 
leukocyte-induced mediators (chapter 4), 
before washing and perfusion with whole 
blood (Figure 2). Here we observed that 
leukocyte-derived mediators induced more 
platelet adherence than TNF-α and that the 
size of the platelet clumps varied depending 
on the type of pathogen used to stimulate 
leukocytes. The TNF-α dose used in the 
Figure 2. Blood coagulation could be another readout for immune cell-endothelial cell 
interaction in sepsis. Platelet coverage on Human Umbilical Vein Endothelial cells (HUVECs) 
cultured in a microfluidic channel perfused with human whole blood, flow direction from left to 
right. Scale bar, 100 µm. Provided by Hugo Albers and Andries Van der Meer, Twente University.
control (10 ng/ml) is higher than the amount 
of TNF-α in the supernatants, therefore other 
mediators should have a role in inducing 
different patterns of coagulation (Figure 2). 
Further experiments are needed to investigate 
whether the variation in platelet adherence is 
caused by IFNs or other cytokines and whether 
it will result in different levels of coagulation.
While there is an on-going discussion 
on the use of IFN type I (IFN-β) for sepsis 
trials, the reasoning behind this trial was 
mainly due to its ability to restore and reverse 
immunosuppression. Therefore, more studies 
on the effect of IFN on endothelial function and 
on coagulation are needed to pre-clinically 
identify the effect of IFN- type I in sepsis.
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Functional genomics approaches could 
complement GWAS to pinpoint genes 
and pathways involved in sepsis
Genetic variations can predispose the 
host to acquire infectious diseases, as well 
as influence their responses to different 
treatments. To identify genetic susceptibility 
factors for infectious diseases, Genome Wide 
Association Studies (GWAS) were conducted 
by focusing on specific types of infectious 
pathogens (virus, bacteria and parasites). 
These studies successfully identified a 
number of loci that predispose carriers to 
infection (Mozzi, Pontremoli & Sironi, 2018). 
Interestingly, most of the identified variants 
were located within genetic loci that are well 
known to be involved in the first responses 
of the innate and adaptive immune system to 
specific features of infectious pathogens. For 
example, variants in the HLA locus were the 
ones most frequently associated with viral 
infections, whereas variants located in Toll-like 
receptor and cytokine genes were commonly 
found to be associated with bacterial infection. 
However, with the current set up for sepsis 
cohort, only one variation was found. It may be 
important to conduct GWAS for sepsis using 
larger cohorts to find genetic variations in 
pathogenic genes and pathways and thereby 
to identify better drug-targets based on host 
genetics. However, this approach remains 
challenging given the practical limits on cohort 
sizes and the extreme clinical heterogeneity 
among sepsis patients.
In addition to GWAS using patient cohorts 
well characterized for clinical parameters and 
infectious pathogens, use of a functional 
genomics approach could be an alternative 
strategy for identifying critical genes and 
pathways and understanding heterogeneity in 
sepsis susceptibility. For example, a genetic 
study in candidemia identified three genome-
wide significant loci: CD58, LCE4A-C1orf68 
and TAGAP (Kumar et al., 2014). Interestingly, 
by applying a functional genomics approach 
to suggestive loci from this study (P <= 10e-
5), Matzaraki et al further prioritized genes 
involved in coagulation and complement 
activation such as SERPINA1 and MAP3K8 
(Matzaraki et al., 2017). Those genes are now 
being validated, and could potentially serve 
as drug targets. Using the same approach, 
we identified 55 genes for sepsis, of which 
the RNA expression levels could be altered 
by genetic variation in 39 suggestive loci. 
Moreover, we also found that these 39 loci 
can also regulate cytokine levels in response 
to various infectious agents. Could these 
genetic variants alter cytokine responses in 
inflammation and sepsis by regulating RNA 
expression of these 55 genes? Further studies 
are required to investigate these gene and 
cytokine pairs: CSGALNACT1 and IL-1β, IL-6, 
TNF-α and IL-22; WLS and IFN-ϒ; CRISPR2 
and IL-6; AOAH and IL-17; and RALA and IL-
1β, TNF-α and IL-6. What these applications do 
show is that the functional genomics approach 
is a promising strategy that can produce 
insights into the mechanisms by which SNPs 
affect disease etiology.
Genetic predisposition for disease 
onset and severity are different and 
have few shared genes
In chapter 2 we identified six genes 
potentially affected by genetic variants 
associated with sepsis onset to be 
significantly different between patients with 
different severity: KLHDC8B, BCS1L, NAT6, 
CSGALNACT1, CYP27A1 and SLC11A1. 
Little is known about the role of NAT6, 
CSGALNACT1 and KLHDC8B in infection 
or sepsis pathogenesis but CYP27A1 and 
SLC11A1 are known to be involved in sepsis 
(chapter 3). CYP27A1 controls the production 
of circulating bile acid and its down regulation 
is considered protective for sepsis patients 
(Matsuzaki et al., 2002; Bhogal & Sanyal, 2013). 
SLC11A1 controls cation metabolism and host 
resistance to infection via formation of an iron 
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channel (Velez et al., 2009). However, further 
studies are needed to test the contribution of 
these genes to sepsis severity. There is no 
evidence for the role of BCS1 in infection, but 
it is potentially a new candidate gene to study 
further. BCS1 encodes for a chaperone protein 
that supports the assembly of complex III in 
the mitochondrial respiratory chain (https://
www.uniprot.org/uniprot/Q9Y276#function). 
Under normal conditions, the mitochondrial 
respiratory chain provides energy (ATP) for the 
cell. It has been shown that the interference 
of respiratory chain activity could result in 
fewer ATP products, which leads to cytopathic 
hypoxia and even apoptosis (Mantzarlis, 
Tsolaki & Zakynthinos, 2017). Studies should 
be conducted to delineate the role of BCS1-
medicated reduction in mitochondrial function 
and whether supplementation of BCS1 can 
restore mitochondrial dysfunction in sepsis. 
Ex-vivo stimulation studies can help 
identify the role of host genetic variation 
in determining the inter-individual 
variability in response to infection
As a complementary approach that helps 
to overcome the challenges of conducting 
studies in patient cohorts, ex-vivo stimulation 
using biomaterials from population-based 
cohorts has been instrumental in identifying 
genetic polymorphisms that significantly 
affect host responses to various types of 
pathogens. Using isolated blood and peripheral 
blood mononuclear blood cells (PBMCs) 
and stimulating them in vitro with various 
pathogens, Li et al identified 12 loci regulate 
cytokine responses (cytokine QTLs) to viral, 
bacterial and fungal infections (Li et al., 2016).
With regards of Candida stimulation, three 
loci were identified that affect TNF-α, IL-22 and 
IL6. By expanding the cytokine profile from six 
cytokines to 92 secreted proteins (chapter 3), 
we identified ten more loci that regulate seven 
proteins: CCL4, VEGF-A, IL8, CXCL9, MCP-1, 
MCP-2 and MCP-3 in PBMCs upon Candida 
albicans stimulation. These chemokines act 
as chemo-attractants to recruit neutrophils, 
basophils and monocytes to the site of infection. 
This study showed that genetics plays a major 
role in regulating the host responses to Candida 
stimulation by regulating the interaction 
between different cell types, at least within 
leukocytes and with endothelial cells. However, 
these kinds of genetic effects on cytokine levels 
are dependent on cell types and stimulation 
conditions (i.e. they are context-specific 
QTLs). Thus, expanding the screening panel 
to include other proteins involved in sepsis-
related phenotypes (such as blood coagulation 
and organ damage), together with experiments 
on relevant cell types and stimulations is 
necessary to widen our understanding on the 
role of genetics in infection.
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When confronting infection, our immune 
system senses and scales the threat of the 
infected pathogen in order to mount a proper 
response that is sufficient to eliminate the 
threat with minimal damage to the tissue. 
This complex and highly regulated immune 
homeostasis can be achieved if the immune 
cells can sense five characteristics of the 
infection episode: 1) formation of phagocytic 
synapses, 2) microbial viability, 3) activity of 
virulence factors, 4) features of invasiveness 
and 5) site of infection (Blander & Sander, 
2012). Our in vitro stimulation experiments 
therefore only capture part of the immune 
response. In the following paragraphs, I 
discuss the limitations of our experimental 
model to study sepsis and how we can 
improve it in the future.
Differences between heat-killed and live 
pathogens in studying inflammation
The use of heat-killed pathogens has 
the advantage of easy handling of infectious 
agents in the lab due to their reduced toxicity, 
and there is no outgrowth of bacteria during 
long experiments. In our in vitro model, we 
observe immune responses to PAMP and 
toxin, that were specific for each type of 
pathogen (chapter 4). For instance, heat-killed 
Streptococcus pneumoniae activated TLR1, 
TLR2 and TLR6 on immune cells at 4 and 24 
hours after stimulation, indicating the presence 
of pneumolysin toxin. However, we missed 
some aspects of the interaction between 
the immune cells and pathogens. Boldrick 
et al (2001) followed the transcriptomic 
changes of PBMCs upon exposure to live 
Bordetella pertussis or heat-killed Bordetella 
pertussis for 12 hours (Boldrick et al., 2001). 
They showed that the heat-killed pathogen 
induced consistently high RNA expression 
of TNF-α, MIP-1β, IL1-α and IL-1β over time, 
LIMITATIONS AND CHALLENGES
whereas live bacteria induced a transient 
increase of those genes that was followed 
by gene suppression. The authors therefore 
suggested that, through interactions with the 
immune cells, the live pathogen can increase 
its survival by suppressing host expression 
of antimicrobial genes. On the other hand, 
Sander et al (2011) showed that live bacteria 
can induce inflammasome activation in 
macrophages and dendritic cells together 
with the common pathways induced by the 
killed pathogens (Sander et al., 2011). Killed 
pathogens can induce IL-1β intracellularly 
(precursor of IL-1β), but cannot induce the 
cleavage of the precursor and secrete IL-1β 
into the environment like the live pathogen can. 
They also suggested that supplementation of 
bacterial RNA into the killed pathogen mix 
can induce the same immunity in both in vitro 
stimulations and humoral responses in mice 
(Sander et al., 2011; Barbet et al., 2018). Future 
studies on the host response to pathogens 
may need to add supplements to the heat-
killed pathogen mix before stimulation to 
overcome the differences between heat-killed 
and live pathogens.
Stimulation of PBMCs may recapitulate 
blood stream infection, however, there are 
roles of other cell types in fighting pathogens
Our in vitro model focused on the 
peripheral blood response to infection. We 
identified inflammatory mediators secreted 
by PBMCs and their impact on endothelial 
transcriptome and cytokine responses 
(chapter 2-4). Cytokines secreted by stimulated 
PBMCs reflected 32 out of 55 inflammatory 
cytokines that circulated in candidemia patient 
serum (chapter 3). On the one hand, this 
indicates that in vitro stimulation studies on 
PBMCs can represent cytokine responses in 
sepsis. But there are also roles for other cell 
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types. Peripheral blood consists of not only 
PBMCs, but also granulocytes or neutrophils 
(40-80% of blood volume) and basophils 
(1% of blood volume) and there are studies 
suggesting important role for neutrophils and 
basophils in sepsis. Neutrophils are critical 
in engulfing and killing bacterial and fungal 
infection and controlling the pathogen burden 
and the spread of infection. Neutrophils can 
kill pathogens by phagocytosis. In candidiasis 
patients, the impairment of neutrophil 
degranulation results in dissemination of 
pathogens and is associated with high 
mortality (Swamydas et al., 2016). Neutrophils 
also secrete neutrophil extracellular traps 
(NETs). NETs consists of chromatin that 
grabs around the host proteins (histones, 
cytosol- and granule-derived proteins) and the 
infected microbes. Due to their antimicrobial 
properties, NETs can kill the pathogens as 
well as trap the microbes, preventing their 
dissemination in the early stage of infection 
(Urban et al., 2006; Bianchi et al., 2011)). 
Neutrophils can also secrete cytokines and 
chemokines, thereby contributing to disease 
progress (as extensively reviewed in (Tecchio, 
Micheletti & Cassatella, 2014). In contrast to 
neutrophils, basophils are less abundant in 
peripheral blood, and the number of studies 
examining the role of basophils in sepsis is 
small. Recently, Piliponsky et al showed that 
basophils are a significant source of TNF in 
a Cecal Ligation Peritoneal- (CLP) mouse 
sepsis model. Basophil-derived TNF has a 
role in enhancing neutrophil and macrophage 
responses to infection (Piliponsky et al., 
2019). Future studies of the host response to 
infection and sepsis should therefore include 
neutrophils and basophils when possible.
The interaction between the immune 
cells and endothelial cells is regulated 
by more factors than just cytokines
Our in vitro study focused on investigating 
the impact of inflammatory mediators secreted 
by activated PBMCs on endothelial cells in a 
static condition and in an indirect manner. 
Therefore, there are other aspects that we 
should improve in the future by incorporating 
flow, characteristics of the endothelial cells 
and direct contact between the immune 
cells and endothelial cells. Upon infection, 
leukocytes migrate from the blood stream 
into the tissue, initiated by their adhesion to 
the vascular wall. The force created by the 
blood flow - shear stress -can affect leukocyte 
adhesion. Moreover, vascular health such 
as integrity, leakage and coagulation are 
also moderated by the flow (O’Neil & Heller, 
2005). Baratchi et al showed that shear stress 
can affect cellular polarization and adherens 
junctions by regulating the clustering and 
translocation of the Transient Receptor 
Potential V4 channel on the cell membrane, 
a receptor for Ca2+ influx (Baratchi et al., 
2017). On the other hand, as discussed in 
chapter 1, endothelial cells derived from 
different vascular beds and organs respond 
differently to stimulation. In this project, we 
used Human Umbilical Vein Endothelial Cells 
(HUVECs) from a pool of donors to represent 
endothelial responses. In addition to their 
lack of vascular-specific response, pooled-
HUVECs cannot be used to reconstruct the 
effects of individual genetic predisposition on 
cellular response to stimulation. Moreover, 
the interaction between immune cells and 
endothelial cells is bidirectional. As proof of 
principle, we stimulated HUVECs with LPS, 
collected the supernatant after 24 hours of 
stimulation, neutralized LPS with polymyxin 
B and exposed the supernatant to PBMCs. 
We observed that the mix of cytokines and 
chemokines secreted by endothelial cells 
in response to LPS activated immune cell 
response. Therefore, future studies should 
incorporate these three factors into the model 
to study how systemic inflammation can result 
in organ damage in each organ.
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As introduced in the preface of this thesis, 
sepsis is a common syndrome caused by 
different infectious pathogens. However, there 
is no common molecular pathway to target 
for treatment in all patients with sepsis. The 
last 40 years of pharmaceutical efforts have 
shown that drugs developed from a model 
mimicking a subgroup of sepsis patients 
cannot benefit the broad and heterogeneous 
pool of patients in general. Here I would like 
to propose future approaches one could take 
to better understand sepsis. These include the 
translational research from bedside to bench 
and back and functional genomics strategies 
that can contribute to our understanding of 
sepsis pathogenesis and the development 
of targeted, personalized, and precision 
medicine for sepsis.
Sepsis patients should be classified into 
subgroups for studies and treatments
There are three main factors that create 
the differences between sepsis patients. 
For one thing, sepsis pathogenesis is 
dependent on several factors including the 
type of infectious pathogen. Sepsis driven 
by Gram-negative bacteria, for instance, has 
a distinctive mechanism when compared to 
other types of infection (Yang et al., 2018). 
Host genetic predisposition has been found 
via variants in multiple genes, that are involved 
in determining various host responses such 
as regulation of the amount of cytokines 
secreted in inflammation and barrier integrity. 
However, the impact of genetic variation to 
sepsis can also vary depending on the initial 
sites of infection (Rautanen et al., 2015, 
Scherag et al., 2016, Srinivasan et al., 2017). 
In addition, host non-genetic factors such as 
comorbidities, health frailty and age are also 
known to be critical factors in determining 
sepsis outcomes. Therefore, sepsis syndrome 
PERSPECTIVES should be sub classified based on the three main factors: pathogen-related factors, host 
non-genetic factors and genetic factors.
Biobanking is necessary to build up a 
database for sepsis patients
Along with patient’s clinical phenotype 
data, patients’ biomaterials including 
urine, blood, feces and biopsies should 
be collected and stored in a biobank in a 
Findable, Accessible, Interoperable and 
Reusable (FAIR) way. Such a biobank will 
allow researchers to access multilayer 
data from patients that covers the genome, 
transcriptome, proteome, metabolome and 
microbiome. It will also be a great resource 
for revealing insights into the similarities and 
differences between each group of patients 
or even each individual. By integrating clinical 
phenotypes with multi-layers of molecular 
omics data in a longitudinal setting, one will 
generate important hypotheses, which can be 
taken up further to validate and investigate the 
molecular mechanisms in the laboratory using 
relevant models.
Preclinical models for sepsis should 
study sepsis-induced organ dysfunction 
in humans
With well-defined phenotypes, we can 
investigate the impact of host genetics, organ-
specific tissue characteristics and how these 
factors shape host responses to infectious 
pathogens. Organ-on-chip technology, for 
example, may allow us to dissect the role 
of each factor, and their interactions, in 
determining different sepsis outcome, in a 
physiologically relevant way. In the blood 
vessel model built on a microfluidic device, 
one can imitate the initial encounter between 
the host and pathogens as well as control 
genetic predisposition by using cells derived 
from induced Pluripotent Stem Cells (iPSCs) 
taken from the same individual. Pathogen-
related factors and, to some extent, host 
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medication use (e.g. immune suppressive 
therapy, drugs for diabetes or antibiotics) can 
also be introduced to the model. Moreover, 
organ-on-chip technology allows us to study 
the interaction between different tissue 
compartments within an organ, or even 
between different organs (Maoz et al., 2018). 
Experiments should be conducted on those 
platforms, which provide readouts that are 
relevant to sepsis, including cytokine profiles, 
leukocyte adherence and immigration, 
vascular leakage, blood coagulation and 
organ dysfunction. Such phenotype readouts 
will bring preclinical studies closer to the clinic 
and therapeutic development.
Metabolome and microbiome may provide 
opportunities to rewrite sepsis outcomes
It is thought that tissue homeostasis 
is important for maintaining organ function 
and the recovery of patients during and after 
sepsis. It includes the balance between cell 
death and proliferation as well as controlling 
the metabolome. Upon exposure to microbial 
stimuli, immune cells such as monocytes 
switch their metabolic pathway from oxidative 
phosphorylation to glycolysis (Kelly & O’Neill, 
2015), or induce both processes depending 
on the type of pathogens and the toll-like 
receptors activated (Lachmandas et al., 
2016). The oxidative phosphorylation pathway 
is a multiple steps process (the TCA cycle) 
that occurs on the mitochondrial membrane. 
Oxidative phosphorylation produces various 
products that, in turn, are the substrates for 
cytokine synthesis and provide a lot of ATP, 
the energy for phagocytosis. However, upon 
activation of TLR, glucose influx is enhanced, 
activating HIF-1α to induce glycolysis. 
Glycolysis, on the other hand, serves as 
a quick but less efficient source of energy. 
Glycolysis is also beneficial for the host cells 
when it enhances IL-1β secretion (Tannahill 
et al., 2013) and uses the mitochondrial 
membrane for synthesizing ROS, an 
antimicrobial agent (Palsson-McDermott & 
O’Neill, 2013). Other evidence has shown that 
the metabolic products play important roles in 
creating memory in innate immune cells via 
epigenetic modification which enable cells to 
produce a stronger response to future infection 
episodes (trained immunity). Substrates from 
metabolism, such as fumarate from the TCA 
cycle of the oxidative phosphorylation pathway 
is essential for epigenetic modification 
(H3K4me3 and H3K27Ac) to boost trained 
immunity (Arts et al., 2016). Glucose, glutamine 
and cholesterol are also important in priming 
trained immunity in monocytes. More studies 
need to be conducted to investigate the long-
term effects of the metabolic switch during 
infection and during sepsis and to determine 
whether trained immunity can be rewired and 
normalized to reach tissue homeostasis after 
sepsis. Studies on role of metabolic pathways 
are crucial since in the end, we cannot edit our 
genetic background, but we can manipulate 
the environment, lifestyle and the diet.
Microbiome can protect the host 
from infection
Early in evolution of life, multicellular 
organisms began serving as an ecological 
niche for unicellular species. Trillions of 
symbiotic microbes have evolved to live in the 
human body, displaying a mutual relationship 
with their human host. Microbiota can be found 
in the gut and skin, contributing to health and 
disease. Other evidence has shown that 
a selective group of microbial species can 
protect the host from infection. For example, 
Proteobacteria, a phylum of Gram-negative 
bacteria, have been shown to increase the 
IgA repertoire and abundance in the serum, 
to increase IgA-induced anti-microbial 
properties, and to thereby protect their mouse 
host from sepsis (Wilmore et al., 2018). 
Moreover, products of microbial metabolism 
can boost the immune responses. Butyrate 
from commensal bacteria reduces glycolysis 
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in macrophages and enhances the maturation 
of the autophagolysosome to degrade 
captured or invasive pathogens (Schulthess 
et al., 2019). Future efforts that profile the 
microbiome within different subtypes of 
In this thesis, we used a functional 
genomics approach to study sepsis 
heterogeneity. In chapter 1, we discussed 
differences in the pathophysiology of sepsis-
associated organ failure. We focused on inter-
organ heterogenic endothelial responses in 
the kidneys and lungs and their contribution 
to organ failure. In chapter 2, we explored 
the functions of genes potentially affected 
by genetic variants associated with sepsis 
onset or sepsis survival. Here we showed 
enrichment of genes associated to sepsis 
for adherens junctions, indicating that barrier 
function has an important role in sepsis 
pathogenesis and host survival. In chapter 
3, we investigated the genetic contribution 
to the amount of cytokines and inflammatory 
circulating proteins in Candida albicans 
infection and in candidemia. From the in vitro 
stimulation experiments, we identified ten 
independent novel protein quantitative trait 
loci, showing that genetics can predispose 
variant carriers to different extent of 
inflammatory responses in infection, at least 
in cytokine production. However, we also 
showed poor correlation of genetic variants 
that contribute to inter-individual variation in 
cytokine response in infection to the onset and 
survival of candidemia patients. This indicates 
that pathways other than just cytokine 
responses from immune cells (Peripheral 
Blood Mononuclear Cells) are involved in 
candidemia susceptibility and survival. In 
chapter 4, we delineated the influence of 
leukocyte-secreted mediators on endothelial 
sepsis patients in order to identify microbial 
species or microbial products that contribute 
to pathogenesis and patient recovery will have 
a strong impact on patient care.
CONCLUSION AND REMARKS
responses. We observed that endothelial 
cells actively contributed to inflammation 
in infection, either by directly responding to 
endotoxin challenge or via mediators secreted 
from activated leukocytes. IL-1 and TNF-α are 
major mediators secreted by leukocytes that 
activate endothelial inflammatory responses. 
We also showed that IFN type I (IFN-α, IFN-β) 
and IFN type III (IFN-ϒ) are independent of 
the IL-1 and TNF-α pathway. The role of IFN 
pathways in endothelial function in sepsis 
therefore remains in need of investigating.
In conclusion, this thesis emphasizes 
the human genetic contributions and the 
interaction between different pathogens and 
the host immune system in infection and 
sepsis. We also emphasize the role of the 
endothelium as an amplifier that can tune 
immune responses. Although the central role 
still lies with inflammation, there are more 
cellular processes and pathways contribute 
to sepsis heterogeneity, in particular to 
barrier integrity and coagulation. We hope 
that the outcomes of our functional genomics 
approach convinces readers of the multi-
faceted nature of sepsis pathogenesis and 
that this work encourages future studies that 
combine patient materials and in vitro studies, 
with the goal of moving forward toward the 
development of new drugs and therapies 
specifically for the different subsets of sepsis 
patients and identification of which group of 
patients will benefit from which current therapies.
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1) Understanding endothelial 
heterogeneous responses may explain organ-
specific failure in sepsis.
2) Functional genomics approaches 
could complement GWAS to pinpoint genes 
and pathways involved in sepsis.
3) Genetic predisposition for sepsis 
onset and severity are different and have few 
shared genes.
4) Host immune responses in sepsis are 
not solely determined by leukocytes, but also 
by the leukocyte-endothelial cell interaction. 
5) Inflammation is central to the fight 
against infectious pathogens, but it should not 
be the sole focus in sepsis research. 
6) Barrier functions, including the 
vascular and intestinal barriers are important 
for sepsis onset and mortality.
7) Interferon pathways should be tested 
in a preclinical model for sepsis.
8) Among the stimuli used in this thesis, 
Candida albicans is the most potent stimulus 
to study the effect of leukoctye-released 
mediators on endothelial cells.
9) Microbiome and metabolome could 
be a way to rewrite sepsis outcomes.
TAKE HOME  
MESSAGES
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To further strengthen the observation on 
endothelial activation upon various stimulation 
at transcriptome levels (chapter 4), we also 
measured the amount of cytokines secreted 
by endothelial cells upon endotoxin challenge 
(Figure S1) or upon stimulation with leukocyte-
derived inflammatory mediators (Figure S2). 
Here we observed a consistent trend in the 
amount of cytokines secreted that agreed with 
our RNAseq data (chapter 4). Among the 91 
chemokines, cytokines and extracellular matrix 
proteinase measured, we detected 68 proteins 
secreted by endothelial cells. Cytokines such 
as IL6 and IL8; chemokines such as CXCL1, 
CXCL6 and CX3CL1; and extracellular matrix 
proteinase such as MMP10 are secreted upon 
LPS challenge (Figure S1). In agreement with 
our RNAseq analysis (chapter 4), endothelial 
cell responses in secreting inflammatory 
mediators were more pronounced when the 
cells were exposed to mediators secreted by 
leukocytes upon whole pathogen stimulation 
(Figure S2). Despite different numbers of 
genes being activated, there were no major 
differences in the amount of cytokines between 
S.pneumoniae- and C.albicans-stimulated 
leukocyte-derived mediators. Endothelial 
cells secreted IL6, uPA, OPG, IL18R1 and 
CX3CL1 (Figure S2). Among these, IL18R1 
and CX3CL1 were the most highly expressed 
in candidemia patients versus healthy controls 
(Chapter 3), indicating that endothelial cell 
cytokines contribute to sepsis. 
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Figure S1. Endothelial cells contributed to the total amount of cytokines secreted upon 
direct exposure to LPS. A. Heatmap shows the average of log2(protein expression) levels 
measured by OLINK® in each condition, ranging from 0-15 (color legends indicated next to the 
heatmap). HUVECs were stimulated with either RPMI (as the negative control) or LPS for six 
hours (ns=3). B. Boxplots of log2(protein expression) (NPX value) for representative proteins 
from each cluster in the heatmap.
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Figure S2. Endothelial cells contributed to the total amount of cytokines secreted upon 
exposure to C.albicans-activated leukocyte-derived mediators.  A. Heatmap shows the 
average of log2(protein expression) levels measured by OLINK® in each condition, ranging 
from 0-15 (color legends next to heatmap). The first two columns are the supernatants from 
24-hour-activated PBMCs with either RPMI or C.albicans (ns=3). The supernatants were then 
added to HUVECs for another 6 hours. The latter two columns are the supernatants collected 
from 6-hour-stimulated HUVECs (ns=3). B. Boxplots of log2(protein expression) (NPX value) for 
representative proteins from each cluster in the heatmap.
